PA5-76559

SLC22A12 antibody from Invitrogen Antibodies

OAT4L, RST, URAT1

Western blot

Supportive data in Antibodypedia

Other assay

Supportive data in Antibodypedia

Provider product page for PA5-76559

Antibody Data

Product number

PA5-76559

Provider

Invitrogen Antibodies

Product name

SLC22A12 Polyclonal Antibody

Provider product page

Antibody type

Polyclonal

Antigen

Recombinant full-length protein

Description

For reconstitution, we recommend adding 100 µL distilled water to a final antibody concentration of about 1 mg/mL. To use this carrier-free antibody for conjugation experiments, we strongly recommend performing another round of desalting. (Zeba Spin Desalting Columns, 7KMWCO, 0.5 mL, Product # 89882)

Reactivity

Human, Mouse, Rat

Host

Rabbit

Isotype

IgG

Vial size

100 µL

Concentration

1 mg/mL

Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

References

Ameliorative effect and mechanism of Yi-Suan-Cha against hyperuricemia in rats.
Qin Y, Zhang X, Tao H, Wu Y, Yan J, Liao L, Meng J, Lin F
Journal of clinical laboratory analysis 2021 Aug;35(8):e23859

Western blot

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Western blot analysis of SLC22A12 in extracts of HepG2 cell line. Samples were incubated with SLC22A12 polyclonal antibody (Product # PA5-76559).

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Western blot analysis of SLC22A12 in extracts of HepG2 cell line. Samples were incubated with SLC22A12 polyclonal antibody (Product # PA5-76559).

Other assay

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

5 FIGURE Effects of Yi-Suan-Cha on the protein levels of renal transporters. Proteins were extracted from the kidney for Western blot analysis of URAT1 (A, B), ABCG2 (A, C), OAT1 (A, D), and GLUT9 (A, E). * p < 0.05 compared to the normal control; # p < 0.05 compared to the hyperuricemia control. Con., control; YC-L, low-dose Yi-Suan-Cha; YC-H, high-dose Yi-Suan-Cha

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

FIGURE 5 Effects of Yi-Suan-Cha on the protein levels of renal transporters. Proteins were extracted from the kidney for Western blot analysis of URAT1 (A, B), ABCG2 (A, C), OAT1 (A, D), and GLUT9 (A, E). * p < 0.05 compared to the normal control; # p < 0.05 compared to the hyperuricemia control. Con., control; YC-L, low-dose Yi-Suan-Cha; YC-H, high-dose Yi-Suan-Cha